CASE REPORT
Adrenocortical carcinoma masquerading as Cushing’s disease
Kush Dev Jarial,1 Rama Walia,1 Santosh Kumar,2 Anil Bhansali1
1Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India 2Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
Correspondence to Dr Anil Bhansali, anilbhansaliendocrine@gmail. com
Accepted 12 March 2017
SUMMARY
Cushing’s syndrome (CS) can be classified as adrenocorticotropic hormone (ACTH)-dependent or ACTH-independent depending on the ACTH levels. However, 30% of the patients with CS have ACTH levels in the ‘grey zone’ (5-20 pg/mL), thereby posing a challenge in establishing the aetiological diagnosis. In a patient with full-blown features of Cushing’s syndrome with equivocal ACTH levels, and a pituitary microadenoma on contrast-enhanced MRI sella, can falsely lead to a diagnosis of Cushing’s disease. Pituitary microadenoma, if <6 mm in size, may be an incidental finding (incidentaloma) in this scenario and can be present in ~3-27% of the healthy population. Therefore, in a patient with CS with equivocal ACTH levels and a pituitary microadenoma, multiple samplings for ACTH and adrenal imaging should be performed to exclude ACTH-independent CS and if required, bilateral inferior petrosal sinus sampling to determine the source of ACTH excess.
BACKGROUND
In patients with Cushing’s syndrome there is a con- siderable overlap in the adrenocorticotropic hormone (ACTH) levels. A patient with overt fea- tures of Cushing’s syndrome with equivocal ACTH levels and pituitary microadenoma of <6 mm in size poses a diagnostic dilemma, as the incidence of pituitary incidentaloma is around 3-27% in the general population.1 In such a scenario ACTH dependency should be established by multiple sam- pling of ACTH or by intravenous corticotropin releasing hormone (CRH) stimulation test. Further, to localise the source of ACTH excess, bilateral inferior petrosal sinus sampling (BIPSS) should be performed to avoid inadvertent pituitary surgery in such cases. We report a case of Cushing’s syndrome with ACTH levels in the ‘grey zone’ and pituitary microadenoma of <6 mm size, who underwent trans-sphenoidal pituitary surgery. However, the patient’s clinical features did not resolve after surgery with persistent biochemical abnormalities, and subsequently on re-evaluation was found to have an adrenocortical carcinoma.
CrossMark
To cite: Jarial KD, Walia R, Kumar S, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2016- 217519
CASE PRESENTATION
A 25-year-old man presented with weight gain, rounding of face, irritability, facial plethora, swelling of legs and generalised weakness of 6 months dur- ation. On examination, he had facial plethora, moon facies, acne, acanthosis nigricans (grade III), viol- aceous purplish striae (>1 cm) over axilla, centripetal obesity, cuticular atrophy, pulp atrophy and proximal
muscle weakness. Systemic examination was unre- markable. Investigations showed 8:00 hours serum cortisol at 800 nmol/L, 16:00 hours serum cortisol at 665 nmol/L, overnight dexamethasone suppression test (ONDST) 670 nmol/L (N<50 nmol/L), midnight ACTH 15.8 pg/mL (single value), and midnight corti- sol 590 nmol/L and T4 4.0 µg/dL. However, other pituitary functions were not assessed. Contrast- enhanced MRI (CEMRI) of sella showed hypoin- tense lesion on the left side of the pituitary measuring 5.5×4.3 mm size (Figure 1). A diagnosis of pituitary ACTH-dependent Cushing’s syndrome was made, and replacement with levothyroxine was started. The patient was subjected to trans-sphenoidal surgery with resection of pituitary microadenoma. Histopathology of the resected tissue was reported as a pituitary adenoma with focal ACTH positivity on immunohistochemistry. Postoperatively, the patient did not improve symptomatically and morning serum cortisol was still 612 nmol/L. ONDST was non- suppressible with a serum cortisol value of 714 nmol/ L. The patient was referred to our institute in view of persistent signs and symptoms, and hypercortisolae- mia. On examination, he had clinical features of hypercortisolism suggestive of persistent disease. Investigations showed 8:00 hours serum cortisol at 978 nmol/L, 23:00 hours serum cortisol at 958 nmol/L, 8:00 hours ACTH<1 pg/mL (multiple values), ONDST 933 nmol/L, low-dose dexametha- sone suppression test 585 nmol/L (N<50 nmol/L), dehydroepiandrosterone Sulphate (DHEAS) 1021 ug/dL (N 160-449), luteinising hormone (LH) 0.2 mIU/mL (N 1.7-8.6), follicle stimulating hormone (FSH) 3.0 mlU/mL (N 1.5-12.4),
COR. T1 DYNAMC STUDY POST GD. 6th PHASE
R
P
I
I
IPL
BMJ
01506086584
CT 2012B F-SP-CR
5-May-2016
4:37:32.34
1 IMA 13
P 242.9
R
10cm
+C
KV-400
eff.mAs 24.1
ref.mAs 261 SL 10.0/128x0.6/p1.2
379-9/0
wat C
130f3 S360.A3eva
PGIMER CHANDIGAR
testosterone 5.8 nmol/L (N 9.9-27.8), oestradiol 31.7 ng/ml (N 7.6-42.6), prolactin 18.4 ng/ml (N 4.0-15.2), T3 1.1 ng/ml (N 0.8-2.0), T4 7.4 µg/dL (N 4.8-12.7), thyroid-stimulating hormone (TSH) 1.7 uIU/mL (N 0.27-4.2) and glycated haemoglobin 5.9%. Dual energy X-ray absorptiometry (DXA) scan showed T score of -0.2 at lumbar spine and -0.9 at femoral neck. Review of the pituitary histopathology was carried out in our institute, which showed normal pituitary gland; however, immunohistochemistry for pituitary hormones was not possible due to paucity of tissue. Contrast enhanced computerised tomography (CECT) abdomen showed heterogeneous enhancing mass lesion with arterial hyper- vascularity in the left suprarenal area measuring 10.7×8.6×11.3 cm (figure 2). 18Fludeoxyglucose (FDG) positron emission tomography-computerised tomography (PET-CT) showed heterogeneous FDG uptake (standardised uptake value (SUV) maximum 14.0) in a well-defined soft tissue mass of size 11.5×9.5×11.7 cm in the left suprarenal area with no hypermeta- bolic tissue elsewhere in the body. Diagnosis of ACTH-independent Cushing’s syndrome due to adrenocortical carcinoma with pituitary incidentaloma was considered and the patient was subjected to left-sided open adrenalectomy. The resected mass measured 10×8×5 cm and weighed 556 g with no capsular breach (European Network for Study of Adrenal Tumour, Stage II). Histopathological examination was suggestive of adreno- cortical carcinoma with modified Weiss score of 4/7.
OUTCOME AND FOLLOW-UP
The patient underwent open left adrenalectomy and postopera- tively the patient was started on hydrocortisone supplementa- tion and mitotane therapy (1000 mg/day in divided doses). Postoperative hormonal evaluation showed 24-hour urine free cortisol at 27 ug/day (off hydrocortisone for 24 hours), testoster- one at 4.98 nmol/L and DHEAS at 5.7 ug/dL. Repeat CECT abdomen did not show any residual lesion and he was subjected to tumour-bed radiotherapy. 18FDG PET-CT is planned on follow-up.
DISCUSSION
We here describe a case of Cushing’s syndrome, which was ini- tially treated as corticotropinoma, as CEMRI sella had shown a microadenoma and ACTH level though a single value, was in the ‘grey zone’. Owing to the persistence of symptoms and
hypercortisolaemia after trans-sphenoidal surgery, the patient was re-evaluated and was found to have ACTH-independent Cushing’s syndrome.
Incidence of endogenous Cushing’s syndrome is 5-10 cases per million per year. Cushing’s disease is the most common cause of Cushing’s syndrome accounting for 70-80% of the cases and out of these 90% are microadenomas and 10% macroadenomas. Adrenal causes contribute 15-20% of all the patients with Cushing’s syndrome including adrenocortical tumour (benign/malignant) or ACTH-independent macronodu- lar adrenal hyperplasia.2 3
Measurement of plasma ACTH levels help in aetiological classification of Cushing’s syndrome as ACTH-dependent or ACTH-independent. However, there is a considerable overlap in the ACTH levels, as 50% of the patients with Cushing’s disease and 25% of the patients with adrenal Cushing’s syn- drome have ACTH levels within normal reference range.4 5 The 8:00 hours plasma ACTH value of <5 pg/mL is suggestive of ACTH-independent Cushing’s syndrome, while 8:00 hours plasma ACTH value of >20 pg/mL is suggestive of ACTH-dependent, and the levels between 5 and 20 pg/mL are in the ‘grey zone’. Patients in the latter group require ACTH and cortisol responses to intravenous CRH stimulation to establish the ACTH dependency.”The plasma ACTH levels in adrenal Cushing’s syndrome may not always be <5 pg/mL
because of slow evolution of the disease and acquired enzym- atic block in the cortisol biosynthesis in the tumour tissue. Similarly, ACTH levels may be in the normal range in patients with Cushing’s disease or sometimes in cyclical Cushing’s syn- drome, due to diurnal variability and pulsatile ACTH secretion, which may not be altered in the early stages of the disease.7 8 Further, heterophile antibodies may also interfere with ACTH assay measured by the electrochemiluminescence immunoassay method ; however, in such a scenario the ACTH levels are usually very high and polyethylene glycol separation is required for correct estimation. This was not observed in the index case as the ACTH levels were in the normal range.9 In most of the studies on ACTH levels have been carried out in the morning or evening; however, it should be carried out when there is nadir of ACTH between 23:00 and 1:00 hours and ACTH level of >22 pg/mL at midnight has been suggested as a cut-off for ACTH dependency.8
In the index case, ACTH value was 15.8 pg/mL and CEMRI sella showed microadenoma, hence a diagnosis of ACTH- dependent pituitary Cushing’s syndrome was made and the patient was subjected to trans-sphenoidal surgery. However, in the presence of short-duration symptoms, male sex and equivocal ACTH level, possibility of aetiologies other than Cushing’s disease should have been considered. The right approach in this case would have been to perform multiple ACTH sampling, and if the ACTH levels are still in the ‘grey zone’, an intravenous CRH stimulation test should have been performed. Patients with adrenal Cushing’s usually show stimulated ACTH values <20 pg/mL, but the patients with Cushing’s disease show a value >20 pg/mL. If the ACTH independency is proved, an imaging for adrenal should be performed. If the ACTH dependency is proved, then BIPSS should be performed as the tumour size was <6 mm. Since 90% of the corticotropinoma are microade- nomas, and in general population the incidence of pituitary inci- dentaloma is up to 3-27%, one should always perform BIPSS in pituitary adenomas of size <6 mm to confirm the ACTH source.” 9-11
The probability of adrenal incidentaloma in such a scenario should not be considered, as the patient had overt features of
Plasma ACTH X2
ACTH<10 pg/ml
ACTH 10-20 pg/ml
ACTH>20 pg/ml
ACTH- independent CS
IVCRH
ACTH- dependent CS
Adrenal CT/ MRI
Peak ACTH <20 pg/ml
Peak ACTH >20 pg/ml
Pituitary MRI
Adenoma <6 mm
Adenoma> 6 mm
IPSS
IVCRH, HDDST
ACTH gradient
No ACTH gradient
Discordant
Concordant
CD
Ectopic CS
CD
Cushing’s syndrome. Adrenal incidentalomas occurs in 0.2-7% of patients, depending on age, and may result in diagnostic con- fusion in presence of equivocal ACTH levels and pituitary microadenoma. Rarely, corticotropinoma may be associated with adrenal nodular enlargement and again ACTH dependency or independency can be judged by ACTH levels. Figure 3 shows a suggested strategy for the differential diagnosis and approach to a patient with Cushing’s syndrome.
Learning points
ACTH values, if in the ‘grey zone’ (10-20 pg/mL), tests should be repeated multiple times in patients with Cushing’s syndrome to establish the aetiological diagnosis.
If ACTH levels are in the ‘grey zone’ adrenal imaging should be performed.
Bilateral inferior petrosal sinus sampling should always be carried out if MRI sella shows a microadenoma <6 mm size to confirm the source of ACTH.
In the index patient, surgery was performed presuming the pituitary incidentaloma to be a corticotropinoma. Pituitary inci- dentalomas are reported on histopathological examination as pituitary adenomas and focal positivity on immunohistochemis- try is due to the presence of normal corticotrope cells, as was seen in the index patient. Further, multiple midnight ACTH measurements on different days may be helpful to determine the ACTH dependency in patients who have ACTH levels in grey zone. Adrenal imaging should be performed in these patients as it is cost-effective in detecting the adrenal pathology.
Contributors KDJ wrote the manuscript and managed the patient. RW edited the manuscript. SK performed surgery. AB edited the manuscript and supervised patient management.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1 Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817-20.
Learning from errors
2 Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526-40.
3 Stratakis CA. Cushing syndrome in pediatrics. Endocrinol Metab Clin North Am 2012;41:793-803.
4 Findling JW. Clinical application of new immunoradiometric assay for ACTH. Endocrinologist 1992;2:360-5.
5 Brossaud J, Bouton M, Gatta B, et al. Use of an automated ACTH assay for the diagnosis of pituitary and adrenal related diseases. Clin Biochem 2011;44:1160-2.
6 Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003;138:980-91.
7 Orth DN. Cushing’s syndrome. N Engl J Med 1995;332:791-803.
8 Melmed S, Williams R. Williams’s textbook of endocrinology. Philadelphia: Elsevier/ Saunders, 2011:516.
9 Gulbahar O, Degertekin CK, Akturk M, et al. A case with immunoassay interference in the measurement of multiple hormones. J Clin Endocrinol Metab 2015;100:2147-53.
10 Jameson J, De Groot L. Endocrinology adult and pediatric. Elsevier-Health Sciences Division, 2016:241.
11 Zampetti B, Grossrubatscher E, Ciaramella P, et al. Bilateral inferior petrosal sinus sampling. Endocr Connect 2016;5:R12-25.
Copyright 2017 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit http://group.bmj.com/group/rights-licensing/permissions.
BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.
Become a Fellow of BMJ Case Reports today and you can:
Submit as many cases as you like
Enjoy fast sympathetic peer review and rapid publication of accepted articles
Access all the published articles
Re-use any of the published material for personal use and teaching without further permission
For information on Institutional Fellowships contact consortiasales@bmjgroup.com
Visit casereports.bmj.com for more articles like this and to become a Fellow